Cassava Sciences (SAVA): Executive Shakeup and Market Reactions

Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company focused on Alzheimer’s disease research, experienced significant developments on July 17, 2024, following major changes in its executive leadership. The Board of Directors announced the appointment of Richard Barry as the new…